Company Analysis

Sophia Genetics Sa (SOPH)

Nasdaq: SOPH · Services-Computer Processing & Data Preparation · Rolle, CH · filing with the SEC since 2021
Grade4.6
◀ Past 6.1● Present 3.1▶ Future 5.0
2 est.

Who runs Sophia Genetics Sa

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Muken Ross
Chief Executive Officer. First filing Mar 2026, latest Nov 9, 2026, 12 filings in all.
Officers reporting now
9
of 15 people with a filing in the last fifteen months
Directors reporting now
6
15 people on the record since 2026
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Camblong JurgiExecutive ChairmanMar 2026Nov 12, 202635 · $2.8M
Van Well DaanChief Legal OfficerMar 2026Nov 12, 202611 · $200,000
Muken RossChief Executive OfficerMar 2026Nov 9, 202614 · $200,000
Cardoza GeorgeChief Financial OfficerMar 2026Nov 9, 20268 · $100,000
Menu PhilippeChief Medical OfficerMar 2026Oct 14, 202624 · $500,000
Xu ZhenyuChief Scientific OfficerMar 2026Oct 14, 202627 · $800,000
Puylaert KevinChief Sales OfficerMar 2026Oct 7, 202612 · $0.00
Valente ManuelaChief People OfficerMar 2026Oct 7, 20269 · $200,000
Verma AbhimanyuChief Technology OfficerMar 2026Oct 7, 20269 · $300,000
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hibbs Kathy LdirectorMar 2026Nov 12, 20264 · $200,000
Cossery Jean-MicheldirectorMar 2026Jun 22, 2026none
Cox TroydirectorMar 2026Jun 22, 2026none
Hirsch DidierdirectorMar 2026Jun 22, 2026none
Ossipow VincentdirectorMar 2026Jun 22, 2026none
Berkovitz TomerdirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SOPH · research, not advice